Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01460810 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01460810: Completed NA study, sponsored by University of Colorado, Denver.

NCT01460810 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01460810, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

A prospective, experimental, case series of 20 patients, with choroidal melanoma, in which pars plana vitrectomy and Silicone oil as vitreous substitute will be used as intraocular shielding for attenuating the deleterious effects of radiation dose delivered to healthy ocular tissue during Iodine-125 plaque brachytherapy treatment and assess if the treatment can reduce the incidence and severity of radiation-induced adverse effects like radiation retinopathy and permanent loss of vision.

Primary Outcome

The loss of 5 or more letters from the base line on an Early Treatment Diabetic Retinopathy Study (ETDRS) chart after 1 and 2 years of follow-up.

Interventions

  • OTHER 1000CsK Silicon Oil Tamponade

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-07
Est. Completion 2021-05-04
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT01460810 record still lists

NCT01460810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which 1000CsK Silicon Oil Tamponade is the first listed.

NCT01460810 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01460810 about?

NCT01460810 is a clinical study titled "Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma". A prospective, experimental, case series of 20 patients, with choroidal melanoma, in which pars plana vitrectomy and Silicone oil as vitreous substitute will be used as intraocular shielding for attenuating the deleterious effects of radiation dose delivered to healthy ocular tissue during Iodine-12...

What is the current status of trial NCT01460810?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2021-05-04.

What interventions are being tested in trial NCT01460810?

The interventions under investigation include: 1000CsK Silicon Oil Tamponade (OTHER).

Who is sponsoring clinical trial NCT01460810?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01460810's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01460810, the US trial registry maintained by the National Library of Medicine. NCT01460810 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.